Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown ...
U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...
Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...
Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of ...
Healthcare distributor Cencora (NYSE:COR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales ...
Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...
Cencora, Inc (NYSE:COR) reported first-quarter 2025 sales increased 12.8% to $81.5 billion, beating the consensus of $78.38 ...
Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.
S&P Global Ratings has revised its outlook on McKesson Corp (NYSE:MCK). to positive from stable, while affirming its 'BBB+' ...
BofA raised the firm’s price target on Cencora (COR) to $270 from $260 and keeps a Neutral rating on the shares following a “good” quarter. The ...
Shares of Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high on Wednesday after the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results